“…The reliable means of detection and quantification of CRP concentration thus becomes important for accurate implementation of therapeutic interventions before and after AMI occurrence for monitoring the status of AMI patients. Besides the traditional expensive and time-consuming methods of CRP testing (Roberts et al, 2000), quantification of CRP using surface plasmon resonance based biosensors (Hu et al, 2006), optical and acoustic biosensors (Luchansky et al, 2011; McBride et al, 2008), enzyme-linked immunosorbent assay (ELISA) (Leung et al, 2005), fluorescence based biosensors (Wolf et al, 2004), magnetic biosensors (Tsai et al, 2007; Martin et al, 2007), electrochemical biosensors based on gold electrode (Bryan et al 2013; Hennessey et al, 2009), magnetic nano-particles (Tsai et al, 2007) etc., has been demonstrated with a wide range of sensitivity, specificity, cost, turn around time (TAT), immunoassay complexity, flexibility for multiplexing, and detection limit (Qureshi et al, 2011).…”